Literature DB >> 25225204

Endothelial dysfunction potentially interacts with impaired glucose metabolism to increase cardiovascular risk.

Guanghong Jia1, James R Sowers2.   

Abstract

Entities:  

Keywords:  cardiovascular disease; population; type 2 diabetes mellitus

Mesh:

Year:  2014        PMID: 25225204      PMCID: PMC4231000          DOI: 10.1161/HYPERTENSIONAHA.114.04348

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  10 in total

Review 1.  Fructose and uric acid: is there a role in endothelial function?

Authors:  Guanghong Jia; Annayya R Aroor; Adam T Whaley-Connell; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2014-06       Impact factor: 5.369

Review 2.  Testing endothelial function and its clinical relevance.

Authors:  Pavel Poredos; Mateja Kaja Jezovnik
Journal:  J Atheroscler Thromb       Date:  2012-09-10       Impact factor: 4.928

3.  Effect of ramipril on the incidence of diabetes.

Authors:  Jackie Bosch; Salim Yusuf; Hertzel C Gerstein; Janice Pogue; Patrick Sheridan; Gilles Dagenais; Rafael Diaz; Alvaro Avezum; Fernando Lanas; Jeffrey Probstfield; George Fodor; Rury R Holman
Journal:  N Engl J Med       Date:  2006-09-15       Impact factor: 91.245

4.  Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women.

Authors:  Yiqing Song; JoAnn E Manson; Lesley Tinker; Nader Rifai; Nancy R Cook; Frank B Hu; Gokhan S Hotamisligil; Paul M Ridker; Beatriz L Rodriguez; Karen L Margolis; Albert Oberman; Simin Liu
Journal:  Diabetes       Date:  2007-03-27       Impact factor: 9.461

5.  Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation.

Authors:  Jeong-A Kim; Hyun-Ju Jang; Luis A Martinez-Lemus; James R Sowers
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-10-25       Impact factor: 4.310

6.  Diabetes mellitus and vascular disease.

Authors:  James R Sowers
Journal:  Hypertension       Date:  2013-05       Impact factor: 10.190

7.  Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn Study.

Authors:  Jolien de Jager; Jacqueline M Dekker; Adriaan Kooy; Piet J Kostense; Giel Nijpels; Rob J Heine; Lex M Bouter; Coen D A Stehouwer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-03-02       Impact factor: 8.311

Review 8.  The assessment of endothelial function: from research into clinical practice.

Authors:  Andreas J Flammer; Todd Anderson; David S Celermajer; Mark A Creager; John Deanfield; Peter Ganz; Naomi M Hamburg; Thomas F Lüscher; Michael Shechter; Stefano Taddei; Joseph A Vita; Amir Lerman
Journal:  Circulation       Date:  2012-08-07       Impact factor: 29.690

9.  Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the framingham offspring study.

Authors:  David S Frankel; James B Meigs; Joseph M Massaro; Peter W F Wilson; Christopher J O'Donnell; Ralph B D'Agostino; Geoffrey H Tofler
Journal:  Circulation       Date:  2008-11-24       Impact factor: 29.690

10.  Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study.

Authors:  Thomas T van Sloten; Ronald M A Henry; Jacqueline M Dekker; Giel Nijpels; Thomas Unger; Miranda T Schram; Coen D A Stehouwer
Journal:  Hypertension       Date:  2014-09-15       Impact factor: 10.190

  10 in total
  17 in total

1.  Role of intestinal Na(+)/H(+) exchanger inhibition in the prevention of cardiovascular and kidney disease.

Authors:  Yan Jia; Guanghong Jia
Journal:  Ann Transl Med       Date:  2015-05

2.  Influences of Recreational Tennis-Playing Exercise Time on Cardiometabolic Health Parameters in Healthy Elderly: The ExAMIN AGE Study.

Authors:  Hsiao-Han Chao; Yi-Hung Liao; Chun-Chung Chou
Journal:  Int J Environ Res Public Health       Date:  2021-01-30       Impact factor: 3.390

3.  Association Between Habitual Night Sleep Duration and Predicted 10-Year Cardiovascular Risk by Sex Among Young and Middle-Aged Adults.

Authors:  Jiangshan He; Yuxue Wang; Li Zhang; Chunjun Li; Xin Qi; Jianxiong Wang; Pei Guo; Shuo Chen; Yujie Niu; Feng Liu; Rong Zhang; Qiang Li; Shitao Ma; Mianzhi Zhang; Chenglin Hong; Minying Zhang
Journal:  Nat Sci Sleep       Date:  2022-05-11

4.  Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus.

Authors:  A E Berezin; A A Kremzer; T A Samura; T A Berezina; P Kruzliak
Journal:  J Endocrinol Invest       Date:  2015-04-28       Impact factor: 4.256

5.  Targeting CITED2 for Angiogenesis in Obesity and Insulin Resistance.

Authors:  Guanghong Jia; James R Sowers
Journal:  Diabetes       Date:  2016-12       Impact factor: 9.461

Review 6.  Obesity, Adipose Tissue and Vascular Dysfunction.

Authors:  Mascha Koenen; Michael A Hill; Paul Cohen; James R Sowers
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

Review 7.  Vascular stiffness in insulin resistance and obesity.

Authors:  Guanghong Jia; Annayya R Aroor; Vincent G DeMarco; Luis A Martinez-Lemus; Gerald A Meininger; James R Sowers
Journal:  Front Physiol       Date:  2015-08-14       Impact factor: 4.566

8.  Caveolin-1 in Cardiovascular Disease: A Double-Edged Sword.

Authors:  Guanghong Jia; James R Sowers
Journal:  Diabetes       Date:  2015-11       Impact factor: 9.461

9.  Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation.

Authors:  Alexander E Berezin; Alexander A Kremzer; Tatyana A Berezina; Yulia V Martovitskaya
Journal:  BBA Clin       Date:  2015-08-03

10.  Endothelium-Derived Hyperpolarizing Factors: A Potential Therapeutic Target for Vascular Dysfunction in Obesity and Insulin Resistance.

Authors:  Guanghong Jia; William Durante; James R Sowers
Journal:  Diabetes       Date:  2016-08       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.